News in brief - November 2013

Other new launches, licence changes and updates relevant to general practice.

Estriol is still available as a cream for the treatment of atrophic vaginitis (pictured) | SCIENCE PHOTO LIBRARY
Estriol is still available as a cream for the treatment of atrophic vaginitis (pictured) | SCIENCE PHOTO LIBRARY
  • Ortho-Gynest (estriol) pessaries have been discontinued.
  • Use of clopidogrel has been associated with a small number of cases of acquired haemophilia; however, the risk-benefit balance of the drug is unchanged.
  • The influenza vaccines Enzira (Pfizer), Fluvirin (Novartis) and Viroflu (Janssen-Cilag) are now available for the current flu season.
  • Travel vaccination advice for some countries, including rabies recommendations for Greece and Spain, has been updated.
  • Stelara (ustekinumab) is now licensed for the treatment of active psoriatic arthritis in adults unresponsive to DMARDs.
  • Ilaris (canakinumab) has been approved for use in patients with active systemic juvenile idiopathic arthritis aged 2 years and older.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases